UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 88.80
+0.90 (1.02%)
Jan 22, 2026, 11:31 AM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 5.33 billion as of January 21, 2026. Its market cap has increased by 30.51% in one year.
Market Cap
5.33B
Enterprise Value
4.80B
Revenue
34.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
88.80
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 5.33B, an increase of 208.67%. That is a compound annual growth rate of 24.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.33B | -1.90% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |